논문정보 : Kang HJ, Kang E, Jo MW, Park EJ, Yoon S, Lee EK. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population. Epilepsy Res. 2014;108(5):963-71.
논문정보 : Davis L, Brunetti L, Lee EK, Yoon N, Cho SH, Suh DC. Effects of computerized physician order entry on medication turnaround time and orders requiring pharmacist intervention. Res Social Adm Pharm. 2014;10(5):756-67.
논문정보 : Choi Y, Jung C, Chae Y, Kang M, Kim J, Joung K, et al. Comparison of validity of mapping between drug indications and ICD-10. Direct and indirect terminology based approaches. Methods Inf Med. 2014;53(3):195-201.
논문정보 : Heo JH, Suh DC, Kim S, Lee EK. Evaluation of the pilot program on the real-time drug utilization review system in South Korea. Int J Med Inform. 2013;82(10):987-95.
논문정보 : Han E, Kim TH, Jeung MJ, Lee EK. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments. Clin Ther. 2013;35(7):941-9.
논문정보 : Cho SK, Sung YK, Choi CB, Kwon JM, Lee EK, Bae SC. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database. Rheumatol Int. 2013;33(12):2985-92.
논문정보 : Park MH, Jo C, Bae EY, Lee EK. A comparison of preferences of targeted therapy for metastatic renal cell carcinoma between the patient group and health care professional group in South Korea. Value Health. 2012;15(6):933-9.
논문정보 : Lim MK, Bae EY, Choi SE, Lee EK, Lee TJ. Eliciting public preference for health-care resource allocation in South Korea. Value Health. 2012;15(1 Suppl):S91-4.
논문정보 : Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, et al. Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. Clin Ther. 2012;34(6):1408-19.
논문정보 : Lee EK, Kim BY, Lim JY, Park MH. Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea. Value Health. 2012;15(1 Suppl):S100-3.
논문정보 : Kang HJ, Kang E, Jo MW, Park EJ, Yoon S, Lee EK. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population. Epilepsy Res. 2014;108(5):963-71.
논문보기 : 10.1016/j.eplepsyres.2014.02.014
논문정보 : Davis L, Brunetti L, Lee EK, Yoon N, Cho SH, Suh DC. Effects of computerized physician order entry on medication turnaround time and orders requiring pharmacist intervention. Res Social Adm Pharm. 2014;10(5):756-67.
논문보기 : 10.1016/j.sapharm.2013.11.004
논문정보 : Choi Y, Jung C, Chae Y, Kang M, Kim J, Joung K, et al. Comparison of validity of mapping between drug indications and ICD-10. Direct and indirect terminology based approaches. Methods Inf Med. 2014;53(3):195-201.
논문보기 : 10.3414/me13-01-0053
논문정보 : Heo JH, Suh DC, Kim S, Lee EK. Evaluation of the pilot program on the real-time drug utilization review system in South Korea. Int J Med Inform. 2013;82(10):987-95.
논문보기 : 10.1016/j.ijmedinf.2013.07.001
논문정보 : Han E, Kim TH, Jeung MJ, Lee EK. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments. Clin Ther. 2013;35(7):941-9.
논문보기 : 10.1016/j.clinthera.2013.05.002
논문정보 : Cho SK, Sung YK, Choi CB, Kwon JM, Lee EK, Bae SC. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database. Rheumatol Int. 2013;33(12):2985-92.
논문보기 : 10.1007/s00296-013-2833-x
논문정보 : Park MH, Jo C, Bae EY, Lee EK. A comparison of preferences of targeted therapy for metastatic renal cell carcinoma between the patient group and health care professional group in South Korea. Value Health. 2012;15(6):933-9.
논문보기 : 10.1016/j.jval.2012.05.008
논문정보 : Lim MK, Bae EY, Choi SE, Lee EK, Lee TJ. Eliciting public preference for health-care resource allocation in South Korea. Value Health. 2012;15(1 Suppl):S91-4.
논문보기 : 10.1016/j.jval.2011.11.014
논문정보 : Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, et al. Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. Clin Ther. 2012;34(6):1408-19.
논문보기 : 10.1016/j.clinthera.2012.05.001
논문정보 : Lee EK, Kim BY, Lim JY, Park MH. Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea. Value Health. 2012;15(1 Suppl):S100-3.
논문보기 : 10.1016/j.jval.2011.11.017